Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study (Diabetologia, (2021), 64, 5, (1066-1078), 10.1007/s00125-021-05392-9)

doi:10.1007/s00125-021-05460-0

科研成果详情

名称	Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study (Diabetologia, (2021), 64, 5, (1066-1078), 10.1007/s00125-021-05392-9)
作者	Ji, Linong 1; Du, Ying 2; Xu, Min 2; Zhou, Xiangjun 2; Mo, Zhaohui 3; Ma, Jianhua 4; Li, Jiarui 5; Li, Yufeng 6; Lin, Jingna 7; Wang, Yanjun 8; Yang, Jing 9; Song, Weihong 10; Jin, Hui 11; Pang, Shuguang 12; Liu, Hui 13; Li, Ping 14,15; Liu, Jie ; Yao, Minxiu 16; Li, Wenhui 17; Jiang, Xiaohong 18; Shen, Feixia19; Geng, Houfa 20; Zhou, Haifeng 21; Ran, Jianmin 22; Lei, Minxiang 23; Du, Yinghong 24; Ye, Shandong 25; Guan, Qingbo 26; Lv, Wenshan 27; Tan, Huiwen 28; Chen, Tao 28; Yang, Jinkui 29; Qin, Guijun 30; Li, Shiyun 31,32; Chen, Lei 33
发表期刊	Diabetologia;
语种	英语
原始文献类型	Erratum
摘要	A Correction to this paper has been published: https://doi.org/10.1007/s00125-021-05460-0.
出版者	SPRINGER
ISSN	0012-186X
EISSN	1432-0428
卷号	64
期号	8
页码	1900-1901
DOI	10.1007/s00125-021-05460-0
页数	2
WOS类目	Endocrinology & Metabolism
WOS研究方向	Endocrinology & Metabolism
WOS记录号	WOS:000654910400001
收录类别	SCOPUS ; SCIE
发布日期	2021-08-01
URL	查看原文
PubMed ID	34037812
通讯作者地址	[Ji, Linong]Peking Univ Peoples Hosp, Dept Endocrinol, Beijing, Peoples R China.
Scopus学科分类	Internal Medicine;Endocrinology, Diabetes and Metabolism
SCOPUSEID	2-s2.0-85106494103
TOP期刊	TOP期刊
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/185312
专题	附属第一医院_内分泌科
通讯作者	Ji, Linong
作者单位	1.Peking Univ Peoples Hosp, Dept Endocrinol, Beijing, Peoples R China; 2.PegBio Co Ltd, Suzhou, Peoples R China; 3.Cent South Univ, Dept Endocrinol, Xiangya Hosp 3, Changsha, Peoples R China; 4.Nanjing First Hosp, Dept Endocrinol, Nanjing, Peoples R China; 5.Cangzhou Cent Hosp, Dept Endocrinol 3, Cangzhou, Peoples R China; 6.Beijing Pinggu Hosp, Dept Endocrinol, Beijing, Peoples R China; 7.Tianjin Peoples Hosp, Dept Endocrinol, Tianjin, Peoples R China; 8.Second Hosp Jilin Univ, Dept Endocrinol, Changchun, Peoples R China; 9.Shanxi Med Univ, Dept Endocrinol, Hosp 1, Taiyuan, Peoples R China; 10.Chenzhou 1 Peoples Hosp, Dept Endocrinol & Diabet, Chenzhou, Peoples R China; 11.Southeast Univ, Dept Endocrinol, Zhongda Hosp, Nanjing, Peoples R China; 12.Jinan Cent Hosp, Dept Endocrinol, Jinan, Peoples R China; 13.Luoyang Cent Hosp, Dept Endocrinol, Luoyang, Peoples R China; 14.Yuncheng Cent Hosp, Dept Endocrinol, Yuncheng, Peoples R China; 15.Henan Univ Sci & Technol, Dept Endocrinol, Affiliated Hosp 1, Luoyang, Henan, Peoples R China; 16.Qingdao Cent Hosp, Dept Endocrinol, Qingdao, Peoples R China; 17.Beijing Union Med Coll Hosp, Dept Endocrinol, Beijing, Peoples R China; 18.First Peoples Hosp Changzhou, Dept Endocrinol, Changzhou, Jiangsu, Peoples R China; 19.Wenzhou Med Univ, Dept Endocrinol, Affiliated Hosp 1, Wenzhou, Peoples R China; 20.Xuzhou Cent Hosp, Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China; 21.First Peoples Hosp, Dept Endocrinol, Changde, Peoples R China; 22.Guangzhou Red Cross Hosp, Dept Endocrinol, Guangzhou, Peoples R China; 23.Cent South Univ, Dept Endocrinol, Xiangya Hosp, Changsha, Peoples R China; 24.Guangzhou Panyu Cent Hosp, Dept Endocrinol, Guangzhou, Peoples R China; 25.Guangzhou Panyu Cent Hosp, Dept Endocrinol, Guangzhou, Peoples R China; 26.Anhui Prov Hosp, Dept Endocrinol, Hefei, Peoples R China; 27.Shandong Prov Hosp, Dept Endocrinol, Jinan, Peoples R China; 28.Qingdao Univ, Dept Endocrinol, Affiliated Hosp, Qingdao, Peoples R China; 29.Sichuan Univ, Dept Endocrinol, Chengdu, Sichuan, Peoples R China; 30.Zhengzhou Univ, Dept Endocrinol, Affiliated Hosp 1, Chengdu, Sichuan, Peoples R China; 31.Chengdu Univ, Dept Endocrinol, Affiliated Hosp, Chengdu, Peoples R China; 32.Chengdu Univ, Dept Endocrinol, Clin Med Coll, Chengdu, Peoples R China; 33.Suzhou Municipal Hosp, Dept Endocrinol, Suzhou, Peoples R China
推荐引用方式 GB/T 7714	Ji, Linong,Du, Ying,Xu, Min,et al. Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study (Diabetologia, (2021), 64, 5, (1066-1078), 10.1007/s00125-021-05392-9). 2021.